Determinants of venous thromboembolic event rates after hip arthroplasty -international comparison
نویسندگان
چکیده
منابع مشابه
Prevention of venous thromboembolic disease after total hip and knee arthroplasty.
Patients undergoing total hip and knee arthroplasty are at increased risk for the development of venous thromboembolic disease, and there is general agreement that these patients require prophylaxis. The selection of a prophylactic agent involves a balance between efficacy and safety and often needs to be individualized for specific patients and institutions. Despite extensive research, the ide...
متن کاملThe John Charnley Award: prevention of readmission for venous thromboembolic disease after total hip arthroplasty.
UNLABELLED Venous thromboembolic disease remains the most common reason for readmission after total hip arthroplasty. Prospective analysis of screening contrast venography was done from 1984 to 2003 in 1972 patients having elective total hip arthroplasty. Patients with deep venous thrombosis or pulmonary embolism received warfarin therapy; those with negative venograms received no further antic...
متن کاملOral anticoagulation strategies after a first idiopathic venous thromboembolic event.
PURPOSE The optimal duration and intensity of warfarin therapy after a first idiopathic venous thromboembolic event are uncertain. We used decision analysis to evaluate clinical and economic outcomes of different anticoagulation strategies with warfarin. METHODS We built a Markov model to assess 6 strategies to treat 40- to 80-year-old men and women after their first idiopathic venous thrombo...
متن کاملPrevention of venous thromboembolism after total hip and knee arthroplasty.
Venous Thromboembolism (VTE) remains a clinical threat to orthopaedic surgeons, despite of a large number of clinical trials and research performed on this subject. Various guidelines and recommendations are available in clinical practice but the search continues for an ideal agent or combination of agents for VTE prophylaxis. Rudolf Virchow first described Deep Vein Thrombosis (DVT) and the su...
متن کاملComparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty. Evaluation during hospitalization and three months after discharge.
BACKGROUND Venous thromboembolic disease in the form of deep venous thrombosis and pulmonary embolism is a major risk after a total hip arthroplasty. Enoxaparin, a low-molecular-weight heparin, has been shown to reduce the prevalence of deep venous thrombosis after total hip arthroplasty. Warfarin, an orally administered anticoagulant, has been used historically to reduce the risk of deep venou...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Journal of Public Health
سال: 2015
ISSN: 1464-360X,1101-1262
DOI: 10.1093/eurpub/ckv172.073